NEDMDG Summer Symposium
Reconnecting the ADME Community through Scientific Exchange
Merck Research Laboratories, 33 Avenue Rd, Louis Pasteur, Boston, MA
May 31st, 2023.
The NEDMDG 2023 Summer Symposium – our first in 4 years – will celebrate the reconnection of our DMPK community by promoting learning, collaboration, and scientific discussion. The symposium features scientific leaders from biotech, pharmaceutical, and academic sectors presenting the latest advancements in DMPK science.
Tom Chan, Senior Principal Scientist, DMPK, Boehringer Ingelheim Pharmaceuticals
Dian Su, Senior Director, DMPK, Bicycle Therapeutics
Diane Ramsden, Director, DMPK, Astrazeneca
Li Di, Research Fellow, Pharmacokinetics, Dynamics & Metabolism, Pfizer Inc.
Cell Therapy/Biologic Modalities
Hanlan Liu, Senior Vice President, Rare Disease & Early Pipeline, Be Biopharma
Hongbin Yu, Oncology Therapeutic Area Lead, Global Development, Boehringer Ingelheim Pharmaceuticals Inc.
Christina Xiaomeng Shen, Senior Principal Scientist, ADMET-BA, Merck Inc.
Machine Learning/Artificial Intelligence for ADME
Alan Cheng, Senior Director, Modeling and Informatics, Merck Inc.
Rajarshi Guha, Senior Director, Data &Computational Sciences, Vertex Pharmaceuticals
Christine Allen, Professor of Pharmaceutics, University of Toronto